Marc Horn took the helm as President of Merck China on January 1st, 2024, with the mandate to drive growth and innovation across the company’s three vital sectors: Life Science, Healthcare, and Electronics.
Career Highlights:
• Proven track record: Joined Merck in 2014 as CFO of China, steadily progressing through roles of increasing responsibility, including Regional CFO of Eastern Asia and Managing Director of the Healthcare business in China.
• Global leadership: In 2017, became a member of the Merck Life Science Executive Leadership Team, serving first as Sector CFO and later as Chief Transformation Officer, demonstrating his strategic acumen and ability to navigate complex global markets.
• Extensive experience: Prior to Merck, gained valuable expertise in various local and global finance roles at Bayer and LANXESS, honing his financial expertise across diverse markets.